Indeed, METTL13-KD increased the expression of the differentiation marker CD11b in HL-60 cells (Fig. 2I and J), suggesting that METTL13 represses the differentiation potential of AML cells. The gene discussed is METTL13; the disease is acute myeloid leukemia.